Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Astera Labs, Inc.ALAB · Entity 1853 | Director | June 04, 2026 | June 09, 2026 |
| BOX INCBOX · Entity 3932 | Director | June 25, 2026 | June 29, 2026 |
| GLOBALFOUNDRIES Inc.GFS · Entity 3198 | Director | July 29, 2026 | July 31, 2026 |
| RESIDEO TECHNOLOGIES, INC.REZI · Entity 1292 | Director | October 01, 2026 | October 05, 2026 |
| SILICON LABORATORIES INC.SLAB · Entity 3682 | Director | September 01, 2021 | September 03, 2021 |
| ThredUp Inc.TDUP · Entity 1057 | Director | September 03, 2024 | September 04, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Astera Labs, Inc.
Report date June 04, 2026 · Filed June 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 85,688 |
Reported balance
After 2026-06-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 837 · Balance 85,688 F1: These shares represent an award of restricted stock units ("RSUs") granted on June 4, 2026 (the "Grant Date") under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. Such award vests in full upon the earlier of (i) the first anniversary of the Grant Date or (ii) the date of the next annual stockholder meeting of the Company following the Grant Date, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F2: Includes deferred stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | Direct | 84,809 |
Reported balance
After 2026-06-04 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-06-04 · Sale · Disposed 879 · Balance 84,809 F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $362.5300 to $363.4350, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes deferred stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | Direct | 83,955 |
Reported balance
After 2026-06-04 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-06-04 · Sale · Disposed 854 · Balance 83,955 F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $360.8100 to $361.6600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes deferred stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | Direct | 82,839 |
Reported balance
After 2026-06-04 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-06-04 · Sale · Disposed 1,116 · Balance 82,839 F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $359.7450 to $360.6600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes deferred stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | Direct | 81,962 |
Reported balance
After 2026-06-04 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2026-06-04 · Sale · Disposed 877 · Balance 81,962 F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $358.8000 to $359.6400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes deferred stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | Direct | 81,079 |
Reported balance
After 2026-06-04 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2026-06-04 · Sale · Disposed 883 · Balance 81,079 F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $357.8650 to $358.6000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes deferred stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | Direct | 80,513 |
Reported balance
After 2026-06-04 transaction · row 7
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 7 · 2026-06-04 · Sale · Disposed 566 · Balance 80,513 F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $356.6600 to $357.5750, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes deferred stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | Direct | 79,567 |
Reported balance
After 2026-06-04 transaction · row 8
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 8 · 2026-06-04 · Sale · Disposed 946 · Balance 79,567 F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F10: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $354.6200 to $355.5800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes deferred stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | Direct | 79,194 |
Reported balance
After 2026-06-04 transaction · row 9
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 9 · 2026-06-04 · Sale · Disposed 373 · Balance 79,194 F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F11: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $354.0600 to $354.5500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes deferred stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | Direct | 78,093 |
Reported balance
After 2026-06-04 transaction · row 10
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 10 · 2026-06-04 · Sale · Disposed 1,101 · Balance 78,093 F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F12: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $352.5400 to $353.5200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes deferred stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | Direct | 77,775 |
Reported balance
After 2026-06-04 transaction · row 11
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 11 · 2026-06-04 · Sale · Disposed 318 · Balance 77,775 F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F13: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $351.5250 to $352.4850, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes deferred stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | Direct | 77,758 |
Reported balance
After 2026-06-04 transaction · row 12
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 12 · 2026-06-04 · Sale · Disposed 17 · Balance 77,758 F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F2: Includes deferred stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | Direct | 77,335 |
Reported balance
After 2026-06-04 transaction · row 13
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 13 · 2026-06-04 · Sale · Disposed 423 · Balance 77,335 F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F14: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $349.1050 to $350.0100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes deferred stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | Direct | 77,142 |
Reported balance
After 2026-06-04 transaction · row 14
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 14 · 2026-06-04 · Sale · Disposed 193 · Balance 77,142 F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F15: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $347.7700 to $347.8600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes deferred stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | Direct | 76,904 |
Reported balance
After 2026-06-04 transaction · row 15
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 15 · 2026-06-04 · Sale · Disposed 238 · Balance 76,904 F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F16: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $346.2700 to $346.6650, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes deferred stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | Direct | 76,658 |
Reported balance
After 2026-06-04 transaction · row 16
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 16 · 2026-06-04 · Sale · Disposed 246 · Balance 76,658 F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F17: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $344.6650 to $345.6250, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes deferred stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | Direct | 76,415 |
Reported balance
After 2026-06-04 transaction · row 17
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 17 · 2026-06-04 · Sale · Disposed 243 · Balance 76,415 F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F18: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $343.9250 to $344.6200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes deferred stock units and dividend equivalent units. |
| Common StockSEC Table I · non-derivative | Direct | 75,888 |
Reported balance
After 2026-06-04 transaction · row 18
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 18 · 2026-06-04 · Sale · Disposed 527 · Balance 75,888 F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F19: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $342.5200 to $343.4600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 75,688 |
Reported balance
After 2026-06-04 transaction · row 19
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 19 · 2026-06-04 · Sale · Disposed 200 · Balance 75,688 F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. F19: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $342.5200 to $343.4600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent an award of restricted stock units ("RSUs") granted on June 4, 2026 (the "Grant Date") under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. Such award vests in full upon the earlier of (i) the first anniversary of the Grant Date or (ii) the date of the next annual stockholder meeting of the Company following the Grant Date, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2: Includes deferred stock units and dividend equivalent units.
F3: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025.
F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $362.5300 to $363.4350, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $360.8100 to $361.6600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $359.7450 to $360.6600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $358.8000 to $359.6400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $357.8650 to $358.6000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $356.6600 to $357.5750, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $354.6200 to $355.5800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F11: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $354.0600 to $354.5500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F12: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $352.5400 to $353.5200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F13: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $351.5250 to $352.4850, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F14: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $349.1050 to $350.0100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F15: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $347.7700 to $347.8600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F16: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $346.2700 to $346.6650, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F17: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $344.6650 to $345.6250, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F18: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $343.9250 to $344.6200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F19: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $342.5200 to $343.4600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
BOX INC
Report date June 25, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 33,727 |
Reported balance
After 2026-06-25 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-25 · Grant · Acquired 8,372 · Balance 33,727 F1: Represents an annual restricted stock unit ("RSU") award pursuant to the Issuer's Outside Director Compensation Policy. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. 100% of the RSUs will vest on the earlier of (i) twelve months from date of grant (i.e. June 25, 2027) or (ii) the date of the Issuer's next annual meeting of stockholders. F2: Certain of these shares are represented by RSUs. Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer subject to the applicable vesting schedule and the Reporting Person's continuous service through each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an annual restricted stock unit ("RSU") award pursuant to the Issuer's Outside Director Compensation Policy. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. 100% of the RSUs will vest on the earlier of (i) twelve months from date of grant (i.e. June 25, 2027) or (ii) the date of the Issuer's next annual meeting of stockholders.
F2: Certain of these shares are represented by RSUs. Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer subject to the applicable vesting schedule and the Reporting Person's continuous service through each such date.
GLOBALFOUNDRIES Inc.
Report date July 29, 2026 · Filed July 31, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Share UnitsSEC Table I · non-derivative | Direct | 3,291 |
Reported balance
Holding disclosure · report date 2026-07-29 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 3,291 F1: Reflects the vesting and settlement of restricted stock units (RSUs) into 5,567 ordinary shares on July 29, 2026. F2: Represents 3,291 RSUs, which vest on July 28, 2027, subject to the reporting person's continued service through the vesting date. Each RSU represents a contingent right to receive one share of the issuer's ordinary shares upon settlement. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 28,094 |
Reported balance
Holding disclosure · report date 2026-07-29 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 28,094 F1: Reflects the vesting and settlement of restricted stock units (RSUs) into 5,567 ordinary shares on July 29, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the vesting and settlement of restricted stock units (RSUs) into 5,567 ordinary shares on July 29, 2026.
F2: Represents 3,291 RSUs, which vest on July 28, 2027, subject to the reporting person's continued service through the vesting date. Each RSU represents a contingent right to receive one share of the issuer's ordinary shares upon settlement.
RESIDEO TECHNOLOGIES, INC.
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 126,680 |
Reported balance
After 2026-10-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 1,811 · Balance 126,680 F1: Issued under the 2018 Stock Plan for Non-Employee Directors of Resideo Technologies, Inc. in lieu of annual cash retainer fees and to be settled by issuance of shares of Common Stock in a lump sum following termination of service as a director. These stock units are fully vested upon grant. F2: Reflects 1,681 restricted stock units acquired pursuant to exempt anti-dilution adjustments in connection with the spin-off of ADI Global Distribution Inc. from Resideo Technologies, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: Issued under the 2018 Stock Plan for Non-Employee Directors of Resideo Technologies, Inc. in lieu of annual cash retainer fees and to be settled by issuance of shares of Common Stock in a lump sum following termination of service as a director. These stock units are fully vested upon grant.
F2: Reflects 1,681 restricted stock units acquired pursuant to exempt anti-dilution adjustments in connection with the spin-off of ADI Global Distribution Inc. from Resideo Technologies, Inc.
SILICON LABORATORIES INC.
Report date September 01, 2021 · Filed September 03, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.0001 par valueSEC Table I · non-derivative | Direct | 10,466 |
Reported balance
After 2021-09-01 transaction · row 1
1 source rowRow 1 · 2021-09-01 · Sale · Disposed 1,353 · Balance 10,466 |
ThredUp Inc.
Report date September 03, 2024 · Filed September 04, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 298,258 |
Reported balance
After 2024-09-03 transaction · row 1
1 source rowRow 1 · 2024-09-03 · Purchase · Acquired 20,000 · Balance 298,258 F1: Open market purchase of shares in accordance with Issuer's trading policies. F2: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.9301 to $0.9584 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: Open market purchase of shares in accordance with Issuer's trading policies.
F2: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.9301 to $0.9584 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Past disclosures · reporting ended (4)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Casper Sleep Inc.
Report date January 25, 2022 · Filed January 26, 2022
Section 16 reporting ended · disclosed 2022-01-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-01-25 transaction · row 1
1 source rowRow 1 · 2022-01-25 · Disposition to issuer · Disposed 50,060 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2021 (the "Merger Agreement"), by and among Casper Sleep Inc. (the "Issuer"), Marlin Parent, Inc. and Marlin Merger Sub, Inc. ("Merger Sub"). On January 25, 2022, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each share of common stock of the Issuer, par value $0.000001 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $6.90 (the "Merger Consideration"), without interest, subject to applicable withholding taxes. F2: In accordance with the Merger Agreement, each restricted stock unit award ("RSU Award") of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was cancelled and converted into the right to receive an amount in cash, subject to applicable withholding taxes, equal to the Merger Consideration multiplied by the number of shares of Issuer common stock subject to such RSU Award. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $15.90 · Expires 2029-04-11 | Direct | 0 |
Reported balance
After 2022-01-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-01-25 · Disposition to issuer · Disposed 1,517 · Balance 0 F4: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger. F3: The options were fully vested and exercisable. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $15.33 · Expires 2028-06-25 | Direct | 0 |
Reported balance
After 2022-01-25 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-01-25 · Disposition to issuer · Disposed 2,260 · Balance 0 F4: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger. F3: The options were fully vested and exercisable. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $15.90 · Expires 2029-03-11 | Direct | 0 |
Reported balance
After 2022-01-25 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-01-25 · Disposition to issuer · Disposed 3,222 · Balance 0 F4: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger. F3: The options were fully vested and exercisable. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $15.90 · Expires 2029-04-11 | Direct | 0 |
Reported balance
After 2022-01-25 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-01-25 · Disposition to issuer · Disposed 60,000 · Balance 0 F4: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger. F5: The options provided for vesting in equal monthly installments over a four year period commencing on May 12, 2019, and would have been fully vested and exercisable on April 12, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2021 (the "Merger Agreement"), by and among Casper Sleep Inc. (the "Issuer"), Marlin Parent, Inc. and Marlin Merger Sub, Inc. ("Merger Sub"). On January 25, 2022, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each share of common stock of the Issuer, par value $0.000001 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $6.90 (the "Merger Consideration"), without interest, subject to applicable withholding taxes.
F2: In accordance with the Merger Agreement, each restricted stock unit award ("RSU Award") of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was cancelled and converted into the right to receive an amount in cash, subject to applicable withholding taxes, equal to the Merger Consideration multiplied by the number of shares of Issuer common stock subject to such RSU Award.
F3: The options were fully vested and exercisable.
F4: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger.
F5: The options provided for vesting in equal monthly installments over a four year period commencing on May 12, 2019, and would have been fully vested and exercisable on April 12, 2023.
Mellanox Technologies, Ltd.
Report date April 27, 2020 · Filed April 27, 2020
Section 16 reporting ended · disclosed 2020-04-27. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2020-04-27 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-04-27 · Disposition to issuer · Disposed 6,449 · Balance 633 F1: Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as March 10, 2019 (the "Merger Agreement"), by and among the Issuer, NVIDIA International Holdings, Inc., a Delaware corporation ("Parent"), Teal Barvaz Ltd., a company organized under the laws of the State of Israel and a wholly owned subsidiary of Parent, and NVIDIA Corporation, a Delaware corporation in exchange for cash consideration of $125.00 per share (the "Per Share Merger Consideration"), subject to any applicable withholding taxes. Row 2 · 2020-04-27 · Disposition to issuer · Disposed 633 · Balance 0 F2: Pursuant to the terms of the Merger Agreement, on April 27, 2020, each outstanding award of restricted stock units ("Issuer RSU") that either (i) had fully vested but had not yet settled in shares or (ii) was held by a non-employee director of the Issuer, whether vested or unvested, was cancelled in exchange for the Per Share Merger Consideration less any applicable withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as March 10, 2019 (the "Merger Agreement"), by and among the Issuer, NVIDIA International Holdings, Inc., a Delaware corporation ("Parent"), Teal Barvaz Ltd., a company organized under the laws of the State of Israel and a wholly owned subsidiary of Parent, and NVIDIA Corporation, a Delaware corporation in exchange for cash consideration of $125.00 per share (the "Per Share Merger Consideration"), subject to any applicable withholding taxes.
F2: Pursuant to the terms of the Merger Agreement, on April 27, 2020, each outstanding award of restricted stock units ("Issuer RSU") that either (i) had fully vested but had not yet settled in shares or (ii) was held by a non-employee director of the Issuer, whether vested or unvested, was cancelled in exchange for the Per Share Merger Consideration less any applicable withholding taxes.
ON Semiconductor Connectivity Solutions, Inc.
Report date June 06, 2019 · Filed June 21, 2019
Section 16 reporting ended · disclosed 2019-06-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2019-06-19 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2019-06-04 · Gift · Disposed 1,634 · Balance 28,299 Row 2 · 2019-06-06 · Grant · Acquired 5,555 · Balance 33,854 F1: Each share is represented by a Restricted Stock Unit ("RSU"). 100% of the RSUs will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's 2020 Annual Meeting occurring after the grant date, in each case, subject to the Reporting Person's continued service as of the applicable vesting date and acceleration of vesting upon a change of control. Row 3 · 2019-06-19 · Disposition to issuer · Disposed 33,854 · Balance 0 F2: Each outstanding share of the Common Stock of the Issuer was converted into the right to receive $24.50 per share in cash, as described in the Merger Agreement. F3: Certain of these securities were RSUs that represented the Reporting Person's right to receive Common Stock shares of the Issuer. The RSUs were subject to acceleration of vesting, cancelled and converted automatically into the right to receive $24.50 per share in cash, as described in the Merger Agreement. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.50 · Expires 2026-07-13 | Direct | 0 |
Reported balance
After 2019-06-19 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-06-19 · Disposition to issuer · Disposed 72,000 · Balance 0 F4: Each outstanding option of the Issuer was either converted into the right to receive cash, or was cancelled without any cash payment or other consideration, as described in the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share is represented by a Restricted Stock Unit ("RSU"). 100% of the RSUs will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's 2020 Annual Meeting occurring after the grant date, in each case, subject to the Reporting Person's continued service as of the applicable vesting date and acceleration of vesting upon a change of control.
F2: Each outstanding share of the Common Stock of the Issuer was converted into the right to receive $24.50 per share in cash, as described in the Merger Agreement.
F3: Certain of these securities were RSUs that represented the Reporting Person's right to receive Common Stock shares of the Issuer. The RSUs were subject to acceleration of vesting, cancelled and converted automatically into the right to receive $24.50 per share in cash, as described in the Merger Agreement.
F4: Each outstanding option of the Issuer was either converted into the right to receive cash, or was cancelled without any cash payment or other consideration, as described in the Merger Agreement.
TUBEMOGUL INC
Report date December 19, 2016 · Filed December 21, 2016
Section 16 reporting ended · disclosed 2016-12-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,069 |
Reported balance
After 2016-12-19 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2016-12-19 · Other · Disposed 26,624 · Balance 8,069 F1: Of the reported shares, 8,069 shares are represented by RSUs. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2016-12-19 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2016-12-19 · Disposition to issuer · Disposed 8,069 · Balance 0 F2: Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated November 10, 2016, by and among Issuer, Adobe Systems Incorporated, a Delaware corporation ("Adobe") and Tiger Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Adobe, the vesting of restricted stock units for an aggregate of 8,069 shares was accelerated immediately at the effective time of the Merger, and in accordance with the Merger Agreement, these accelerated restricted stock units were canceled and converted into the right to receive cash consideration of $14.00 per share, net to the seller in cash, without interest thereon and subject to any required tax withholding. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.37 · Expires 2025-06-18 | Direct | 0 |
Reported balance
After 2016-12-19 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-12-19 · Disposition to issuer · Disposed 5,679 · Balance 0 F3: This stock option is being canceled pursuant to the terms of the Merger Agreement. F4: This stock option is fully vested and exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.76 · Expires 2023-11-11 | Direct | 0 |
Reported balance
After 2016-12-19 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2016-12-19 · Disposition to issuer · Disposed 107,500 · Balance 0 F5: Option is fully vested and immediately exercisable. Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding and exercisable option to purchase shares of common stock of Issuer was canceled and converted into the right to receive an amount (subject to any applicable withholding tax) in cash equal to: (A) $14.00 per share minus (B) the exercise price per share of common stock of Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Of the reported shares, 8,069 shares are represented by RSUs.
F2: Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated November 10, 2016, by and among Issuer, Adobe Systems Incorporated, a Delaware corporation ("Adobe") and Tiger Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Adobe, the vesting of restricted stock units for an aggregate of 8,069 shares was accelerated immediately at the effective time of the Merger, and in accordance with the Merger Agreement, these accelerated restricted stock units were canceled and converted into the right to receive cash consideration of $14.00 per share, net to the seller in cash, without interest thereon and subject to any required tax withholding.
F3: This stock option is being canceled pursuant to the terms of the Merger Agreement.
F4: This stock option is fully vested and exercisable.
F5: Option is fully vested and immediately exercisable. Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding and exercisable option to purchase shares of common stock of Issuer was canceled and converted into the right to receive an amount (subject to any applicable withholding tax) in cash equal to: (A) $14.00 per share minus (B) the exercise price per share of common stock of Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 03, 2022 Filed Oct 5, 2022 20:30 UTC | RESIDEO TECHNOLOGIES, INC. REZI · Entity 1292 | GrantCommon Stock | 1,528 | $19.64 | $30,009.92 |
DisclosureSEC source: 0001209191-22-052755 · doc4.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,048 F1 · kind: Issued under the 2018 Stock Plan for Non-Employee Directors of Resideo Technologies, Inc. in lieu of annual cash retainer fees and to be settled by issuance of shares of Common Stock in a lump sum following termination of service as a director. These stock units are fully vested upon grant. Read SEC document |
| August 02, 2022 Filed Aug 4, 2022 21:30 UTC | ThredUp Inc. TDUP · Entity 1057 | GrantClass A Common Stock | 6,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001484778-22-000131 · wf-form4_165964857805049.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,733 F1 · kind: Grant of fully vested restricted stock units ("RSUs") under the Issuer's 2021 Stock Option and Incentive Plan in a transaction exempt under Rule 16b-3. Each unit represents a right to receive one share of the Issuer's Class A Common Stock. The Reporting Person elected to receive RSUs in lieu of his annual cash retainer, which retainer is paid in quarterly installments. Read SEC document |
| July 14, 2022 Filed Jul 15, 2022 21:39 UTC | BOX INC BOX · Entity 3932 | GrantClass A Common Stock | 7,773 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-042294 · doc4.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,555 F1 · shares: Represents an annual restricted stock unit (RSU) award pursuant to the Issuer's Outside Director Compensation Policy. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. 100% of the RSUs will vest on the earlier of (i) twelve months from date of grant (i.e. July 14, 2023) or (ii) the date of the Issuer's next annual meeting of stockholders. F2 · balance_after: Certain of these shares are represented by RSUs. Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer subject to the applicable vesting schedule and the Reporting Person's continuous service through each such date. Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:30 UTC | RESIDEO TECHNOLOGIES, INC. REZI · Entity 1292 | GrantCommon Stock | 1,548 | $19.38 | $30,000.24 |
DisclosureSEC source: 0001209191-22-040706 · doc4.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,520 F1 · kind: Issued under the 2018 Stock Plan for Non-Employee Directors of Resideo Technologies, Inc. in lieu of annual cash retainer fees and to be settled by issuance of shares of Common Stock in a lump sum following termination of service as a director. These stock units are fully vested upon grant. Read SEC document |
| June 08, 2022 Filed Jun 11, 2022 01:00 UTC | RESIDEO TECHNOLOGIES, INC. REZI · Entity 1292 | GrantCommon Stock | 6,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-036190 · doc4.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,972 F1 · balance_after: Includes 21,821 of prior restricted stock units previously reported on Table II that are being transferred to Table I for reporting purposes. Read SEC document |
| May 26, 2022 Filed May 27, 2022 21:34 UTC | ThredUp Inc. TDUP · Entity 1057 | GrantClass A Common Stock | 19,613 | $0.00 | $0.00 |
DisclosureSEC source: 0001484778-22-000092 · wf-form4_165368726699016.xml · nonDerivative · entry 2 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,030 F2 · kind: These shares represent RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock. The RSUs vest in full on the earlier of (i) May 26, 2023 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer on such date. Read SEC document |
| May 25, 2022 Filed May 27, 2022 21:34 UTC | ThredUp Inc. TDUP · Entity 1057 | GrantClass A Common Stock | 1,961 | $0.00 | $0.00 |
DisclosureSEC source: 0001484778-22-000092 · wf-form4_165368726699016.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,417 F1 · kind: Grant of fully vested restricted stock units ("RSUs") under the Issuer's 2021 Stock Option and Incentive Plan in a transaction exempt under Rule 16b-3. Each unit represents a right to receive one share of the Issuer's Class A Common Stock. The Reporting Person elected to receive RSUs in lieu of his annual cash retainer, which retainer is paid in quarterly installments. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 20:31 UTC | RESIDEO TECHNOLOGIES, INC. REZI · Entity 1292 | GrantCommon Stock | 1,241 | $24.16 | $29,982.56 |
DisclosureSEC source: 0001209191-22-022396 · doc4.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,871 F1 · kind: Issued under the 2018 Stock Plan for Non-Employee Directors of Resideo Technologies, Inc. in lieu of annual cash retainer fees and to be settled by issuance of shares of Common Stock in a lump sum following termination of service as a director. These stock units are fully vested upon grant. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:32 UTC | ThredUp Inc. TDUP · Entity 1057 | ConversionClass B Common Stock · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484778-22-000038 · wf-form4_164703426581719.xml · derivative · entry 5 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B is convertible into one share of Class A Common Stock at the option of the holder and upon the occurrence of other events set forth in the Issuer's Certificate of Incorporation. F1 · kind: Each share of Class B is convertible into one share of Class A Common Stock at the option of the holder and upon the occurrence of other events set forth in the Issuer's Certificate of Incorporation. F1 · derivative.exercise_date: Each share of Class B is convertible into one share of Class A Common Stock at the option of the holder and upon the occurrence of other events set forth in the Issuer's Certificate of Incorporation. F1 · derivative.expiration_date: Each share of Class B is convertible into one share of Class A Common Stock at the option of the holder and upon the occurrence of other events set forth in the Issuer's Certificate of Incorporation. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:32 UTC | ThredUp Inc. TDUP · Entity 1057 | Exercise / conversionClass B Common Stock · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484778-22-000038 · wf-form4_164703426581719.xml · derivative · entry 4 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B is convertible into one share of Class A Common Stock at the option of the holder and upon the occurrence of other events set forth in the Issuer's Certificate of Incorporation. F1 · derivative.exercise_date: Each share of Class B is convertible into one share of Class A Common Stock at the option of the holder and upon the occurrence of other events set forth in the Issuer's Certificate of Incorporation. F1 · derivative.expiration_date: Each share of Class B is convertible into one share of Class A Common Stock at the option of the holder and upon the occurrence of other events set forth in the Issuer's Certificate of Incorporation. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:32 UTC | ThredUp Inc. TDUP · Entity 1057 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001484778-22-000038 · wf-form4_164703426581719.xml · derivative · entry 3 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,994 Underlying: Class B Common Stock · 25,000 shares Expires 2027-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vests in 48 equal monthly installments after June 23, 2017, subject to the Reporting Person's continued service with the Issuer as of each vesting date. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:32 UTC | ThredUp Inc. TDUP · Entity 1057 | PurchaseClass A Common Stock | 13,156 | $7.51 | $98,775.25 |
DisclosureSEC source: 0001484778-22-000038 · wf-form4_164703426581719.xml · nonDerivative · entry 2 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,456 F2 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $7.45 to $7.67 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 21:32 UTC | ThredUp Inc. TDUP · Entity 1057 | ConversionClass A Common Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484778-22-000038 · wf-form4_164703426581719.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each share of Class B is convertible into one share of Class A Common Stock at the option of the holder and upon the occurrence of other events set forth in the Issuer's Certificate of Incorporation. F1 · price: Each share of Class B is convertible into one share of Class A Common Stock at the option of the holder and upon the occurrence of other events set forth in the Issuer's Certificate of Incorporation. Read SEC document |
| March 09, 2022 Filed Apr 6, 2023 20:23 UTC Amendment | ThredUp Inc. TDUP · Entity 1057 | PurchaseClass A Common Stock | 13,156 | $7.51 | $98,775.25 |
DisclosureSEC source: 0001484778-23-000079 · wf-form4a_168081259755683.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Lazar 2012 Living Trust Disclosed balance after: 13,156 F1 · price: The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $7.45 to $7.67 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Holding is being revised to add 13,156 shares of Class A common stock that are held by the Lazar 2012 Living Trust and that due to an administrative error were incorrectly previously reported as directly owned by the Reporting Person. The amount of securities is as of 04/06/2023. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 21:17 UTC | ThredUp Inc. TDUP · Entity 1057 | GrantClass A Common Stock | 1,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001484778-22-000027 · wf-form4_164504620298255.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,300 F1 · kind: Grant of fully vested restricted stock units ("RSUs") under the Issuer's 2021 Stock Option and Incentive Plan in a transaction exempt under Rule 16b-3. Each unit represents a right to receive one share of the Issuer's Class A Common Stock. The Reporting Person elected to receive RSUs in lieu of his annual cash retainer, which retainer is paid in quarterly installments. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 21:17 UTC | Casper Sleep Inc. CSPR · Entity 131068 | Disposition to issuerStock Option · Derivative | 60,000 | $0.00 Strike: $15.90 | $0.00 |
DisclosureSEC source: 0001598674-22-000026 · wf-form4_164323183458600.xml · derivative · entry 5 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,000 shares Expires 2029-04-11 F4 · price: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger. F5 · derivative.exercise_date: The options provided for vesting in equal monthly installments over a four year period commencing on May 12, 2019, and would have been fully vested and exercisable on April 12, 2023. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 21:17 UTC | Casper Sleep Inc. CSPR · Entity 131068 | Disposition to issuerStock Option · Derivative | 3,222 | $0.00 Strike: $15.90 | $0.00 |
DisclosureSEC source: 0001598674-22-000026 · wf-form4_164323183458600.xml · derivative · entry 4 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,222 shares Expires 2029-03-11 F4 · price: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger. F3 · derivative.exercise_date: The options were fully vested and exercisable. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 21:17 UTC | Casper Sleep Inc. CSPR · Entity 131068 | Disposition to issuerStock Option · Derivative | 2,260 | $0.00 Strike: $15.33 | $0.00 |
DisclosureSEC source: 0001598674-22-000026 · wf-form4_164323183458600.xml · derivative · entry 3 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,260 shares Expires 2028-06-25 F4 · price: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger. F3 · derivative.exercise_date: The options were fully vested and exercisable. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 21:17 UTC | Casper Sleep Inc. CSPR · Entity 131068 | Disposition to issuerStock Option · Derivative | 1,517 | $0.00 Strike: $15.90 | $0.00 |
DisclosureSEC source: 0001598674-22-000026 · wf-form4_164323183458600.xml · derivative · entry 2 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,517 shares Expires 2029-04-11 F4 · price: In accordance with the Merger Agreement, each option to acquire common stock of the Issuer that was unvested or had a per share exercise price equal to or greater than the Merger Consideration was cancelled for no consideration as of the effective time of the Merger. F3 · derivative.exercise_date: The options were fully vested and exercisable. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 21:17 UTC | Casper Sleep Inc. CSPR · Entity 131068 | Disposition to issuerCommon Stock | 50,060 | $6.90 | $345,414.00 |
DisclosureSEC source: 0001598674-22-000026 · wf-form4_164323183458600.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2021 (the "Merger Agreement"), by and among Casper Sleep Inc. (the "Issuer"), Marlin Parent, Inc. and Marlin Merger Sub, Inc. ("Merger Sub"). On January 25, 2022, upon the closing of the merger of Merger Sub with and into the Issuer (the "Merger") contemplated by the Merger Agreement, each share of common stock of the Issuer, par value $0.000001 per share, was cancelled and automatically converted into the right to receive an amount in cash equal to $6.90 (the "Merger Consideration"), without interest, subject to applicable withholding taxes. F2 · price: In accordance with the Merger Agreement, each restricted stock unit award ("RSU Award") of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was cancelled and converted into the right to receive an amount in cash, subject to applicable withholding taxes, equal to the Merger Consideration multiplied by the number of shares of Issuer common stock subject to such RSU Award. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 21:30 UTC | RESIDEO TECHNOLOGIES, INC. REZI · Entity 1292 | Exercise / conversionRestricted Stock Units · Derivative | 5,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-065478 · doc4.xml · derivative · entry 2 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,579 Underlying: Common Stock · 5,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Instrument converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: On November 16, 2018, the reporting person was granted 11,157 restricted stock units, vesting as to 50% on November 16, 2021 and 50% on November 16, 2022, or if earlier, upon the director's death or disability or removal from the board of directors of Resideo coincident with the occurrence of a change of control. F2 · derivative.expiration_date: On November 16, 2018, the reporting person was granted 11,157 restricted stock units, vesting as to 50% on November 16, 2021 and 50% on November 16, 2022, or if earlier, upon the director's death or disability or removal from the board of directors of Resideo coincident with the occurrence of a change of control. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 21:30 UTC | RESIDEO TECHNOLOGIES, INC. REZI · Entity 1292 | Exercise / conversionCommon Stock | 5,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-065478 · doc4.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,630 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2021 Filed Sep 10, 2021 22:01 UTC | BOX INC BOX · Entity 3932 | GrantClass A Common Stock | 7,949 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-055541 · doc4.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,782 F1 · shares: Represents an automatic annual restricted stock unit (RSU) award pursuant to the Issuer's Outside Director Compensation Policy. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. 100% of the RSUs vest on the earlier of September 9, 2022 or the Issuer's next annual meeting of stockholders. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 16:55 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 1,353 | $160.00 | $216,480.00 |
DisclosureSEC source: 0001681108-21-000046 · primary_doc.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,466 Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 21:44 UTC | Casper Sleep Inc. CSPR · Entity 131068 | GrantCommon Stock | 16,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001598674-21-000055 · wf-form4_162370704540868.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,060 F1 · shares: Represents 16,062 deferred stock units. Each deferred stock unit represents a contingent right to receive one share of common stock. The deferred stock units will vest on the earlier of (i) the day immediately preceding the 2022 Annual Meeting of Stockholders and (ii) June 10, 2022 and, pursuant to an election made by the Reporting Person, will settle in full 90 days after the Reporting Person ceases to serve on the Company's Board of Directors. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 20:32 UTC | RESIDEO TECHNOLOGIES, INC. REZI · Entity 1292 | GrantRestricted Stock Units · Derivative | 4,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039472 · doc4.xml · derivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,070 Underlying: Common Stock · 4,070 shares Expires not disclosed F1 · derivative.exercise_price: Grant of restricted stock units issued under the 2018 Stock Plan for Non-Employee Directors of Resideo Technologies, Inc. which, subject to earlier forfeiture, will vest on June 9, 2022. F1 · derivative.exercise_date: Grant of restricted stock units issued under the 2018 Stock Plan for Non-Employee Directors of Resideo Technologies, Inc. which, subject to earlier forfeiture, will vest on June 9, 2022. F1 · derivative.expiration_date: Grant of restricted stock units issued under the 2018 Stock Plan for Non-Employee Directors of Resideo Technologies, Inc. which, subject to earlier forfeiture, will vest on June 9, 2022. Read SEC document |
| April 22, 2021 Filed Apr 23, 2021 18:04 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | GrantCommon Stock, $0.0001 par value | 1,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001681108-21-000022 · primary_doc.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,819 F1 · shares: Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of common stock per RSU. The RSUs will vest completely on the earlier of (i) the first (1st) anniversary of the date of grant, and (ii) the date one day prior to the Annual Meeting of Stockholders in the year following the grant date. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 22:28 UTC | ThredUp Inc. TDUP · Entity 1057 | OtherStock Option (Right to Buy) · Derivative | 281,994 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001628280-21-006423 · wf-form4_161731603360474.xml · derivative · entry 5 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,994 Underlying: Class B Common Stock · 281,994 shares Expires 2027-07-06 F4 · kind: Immediately prior to the closing of the Issuer's initial public offering and following the conversion of each series of the Issuer's convertible preferred stock into Common Stock, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. F5 · derivative.exercise_date: The stock option vests in 48 equal monthly installments after June 23, 2017, subject to the Reporting Person's continued service with the Issuer as of each vesting date. F3 · derivative.underlying: Each share of Class B is convertible into one share of Class A Common Stock at the option of the holder and upon the occurrence of other events set forth in the Issuer's Certificate of Incorporation. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 22:28 UTC | ThredUp Inc. TDUP · Entity 1057 | OtherStock Option (Right to Buy) · Derivative | 281,994 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001628280-21-006423 · wf-form4_161731603360474.xml · derivative · entry 4 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 281,994 shares Expires 2027-07-06 F4 · kind: Immediately prior to the closing of the Issuer's initial public offering and following the conversion of each series of the Issuer's convertible preferred stock into Common Stock, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. F5 · derivative.exercise_date: The stock option vests in 48 equal monthly installments after June 23, 2017, subject to the Reporting Person's continued service with the Issuer as of each vesting date. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 22:28 UTC | ThredUp Inc. TDUP · Entity 1057 | OtherClass B Common Stock · Derivative | 31,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-006423 · wf-form4_161731603360474.xml · derivative · entry 3 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Lazar 2012 Living Trust Disclosed balance after: 31,958 Underlying: Class A Common Stock · 31,958 shares Expires not disclosed F3 · derivative.exercise_price: Each share of Class B is convertible into one share of Class A Common Stock at the option of the holder and upon the occurrence of other events set forth in the Issuer's Certificate of Incorporation. F4 · kind: Immediately prior to the closing of the Issuer's initial public offering and following the conversion of each series of the Issuer's convertible preferred stock into Common Stock, each share of Common Stock was reclassified into one share of Class B Common Stock in an exempt transaction pursuant to Rule 16b-7. F3 · derivative.exercise_date: Each share of Class B is convertible into one share of Class A Common Stock at the option of the holder and upon the occurrence of other events set forth in the Issuer's Certificate of Incorporation. F3 · derivative.expiration_date: Each share of Class B is convertible into one share of Class A Common Stock at the option of the holder and upon the occurrence of other events set forth in the Issuer's Certificate of Incorporation. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 22:28 UTC | ThredUp Inc. TDUP · Entity 1057 | ConversionSeries E-1 Preferred Stock · Derivative | 31,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-006423 · wf-form4_161731603360474.xml · derivative · entry 2 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Lazar 2012 Living Trust Disclosed balance after: 0 Underlying: Common Stock · 31,958 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Immediately prior to the closing of the Issuer's initial public offering, each share of Series E-1 Preferred Stock automatically converted into one share of the Issuer's Common Stock, par value $0.0001 per share, on a one-for-one basis. The Series E-1 Preferred Stock had no expiration date. F2 · derivative.exercise_date: Immediately prior to the closing of the Issuer's initial public offering, each share of Series E-1 Preferred Stock automatically converted into one share of the Issuer's Common Stock, par value $0.0001 per share, on a one-for-one basis. The Series E-1 Preferred Stock had no expiration date. F2 · derivative.expiration_date: Immediately prior to the closing of the Issuer's initial public offering, each share of Series E-1 Preferred Stock automatically converted into one share of the Issuer's Common Stock, par value $0.0001 per share, on a one-for-one basis. The Series E-1 Preferred Stock had no expiration date. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 22:28 UTC | ThredUp Inc. TDUP · Entity 1057 | PurchaseClass A Common Stock | 7,142 | $14.00 | $99,988.00 |
DisclosureSEC source: 0001628280-21-006423 · wf-form4_161731603360474.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,856 F1 · kind: Represents the purchase of shares of Class A common stock of the Issuer in the Issuer's directed share program in connection with its initial public offering. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 22:34 UTC | ThredUp Inc. TDUP · Entity 1057 | GrantClass A Common Stock | 10,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-006012 · wf-form4_161705723148797.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,714 F1 · shares: These shares represent restricted stock units (each, an "RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock. The RSUs vest in full on the earlier of (i) March 25, 2022 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 23:45 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 1,500 | $129.75 | $194,625.00 |
DisclosureSEC source: 0001681108-21-000001 · primary_doc.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,576 F1 · shares: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. Read SEC document |
| November 18, 2020 Filed Nov 19, 2020 22:24 UTC | RESIDEO TECHNOLOGIES, INC. REZI · Entity 1292 | PurchaseCommon Stock | 6,666 | $15.00 | $99,990.00 |
DisclosureSEC source: 0001209191-20-059472 · doc4.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,052 F1 · shares: Represents a purchase from the underwriter in registered public equity offering that closed on November 18, 2020. Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 20:15 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 1,500 | $119.75 | $179,625.00 |
DisclosureSEC source: 0001681108-20-000062 · primary_doc.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,076 F1 · shares: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. Read SEC document |
| November 05, 2020 Filed Nov 10, 2020 00:55 UTC Amendment | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 2,000 | $109.75 | $219,500.00 |
DisclosureSEC source: 0001681108-20-000056 · primary_doc.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,576 F2 · kind: This amendment on Form 4/A to the Form 4 originally filed on November 9, 2020 (the Original Form 4) is made solely to correct the Transaction Code in Item 3, which should have been reported as Code S on the Original Form 4. F1 · shares: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. Read SEC document |
| November 05, 2020 Filed Nov 9, 2020 15:47 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | Disposition to issuerCommon Stock, $0.0001 par value | 2,000 | $109.75 | $219,500.00 |
DisclosureSEC source: 0001681108-20-000052 · primary_doc.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,576 F1 · shares: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 14:39 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | SaleCommon Stock, $0.0001 par value | 1,000 | $104.75 | $104,750.00 |
DisclosureSEC source: 0001681108-20-000045 · primary_doc.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,576 F1 · shares: Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 00:56 UTC | RESIDEO TECHNOLOGIES, INC. REZI · Entity 1292 | Exercise / conversionRestricted Stock Units · Derivative | 5,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-036837 · doc4.xml · derivative · entry 2 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,799 shares Expires 2020-06-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Instrument converts to common stock on a one-for-one basis. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 00:56 UTC | RESIDEO TECHNOLOGIES, INC. REZI · Entity 1292 | Exercise / conversionCommon Stock | 5,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-036837 · doc4.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 21:23 UTC | RESIDEO TECHNOLOGIES, INC. REZI · Entity 1292 | GrantRestricted Stock Units · Derivative | 12,172 | $9.86 | $120,015.92 |
DisclosureSEC source: 0001209191-20-035326 · doc4.xml · derivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,172 Underlying: Common Stock · 12,172 shares Expires not disclosed F1 · derivative.exercise_price: Grant of restricted stock units issued under the 2018 Stock Plan for Non-Employee Directors of Resideo Technologies, Inc. which, subject to earlier forfeiture, will vest on June 8, 2021. F1 · derivative.exercise_date: Grant of restricted stock units issued under the 2018 Stock Plan for Non-Employee Directors of Resideo Technologies, Inc. which, subject to earlier forfeiture, will vest on June 8, 2021. F1 · derivative.expiration_date: Grant of restricted stock units issued under the 2018 Stock Plan for Non-Employee Directors of Resideo Technologies, Inc. which, subject to earlier forfeiture, will vest on June 8, 2021. Read SEC document |
| April 27, 2020 Filed Apr 27, 2020 19:46 UTC | Mellanox Technologies, Ltd. MLNX · Entity 13120 | Disposition to issuerOrdinary Shares | 633 | $125.00 | $79,125.00 |
DisclosureSEC source: 0001567619-20-008475 · doc1.xml · nonDerivative · entry 2 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: Pursuant to the terms of the Merger Agreement, on April 27, 2020, each outstanding award of restricted stock units ("Issuer RSU") that either (i) had fully vested but had not yet settled in shares or (ii) was held by a non-employee director of the Issuer, whether vested or unvested, was cancelled in exchange for the Per Share Merger Consideration less any applicable withholding taxes. Read SEC document |
| April 27, 2020 Filed Apr 27, 2020 19:46 UTC | Mellanox Technologies, Ltd. MLNX · Entity 13120 | Disposition to issuerOrdinary Shares | 6,449 | $125.00 | $806,125.00 |
DisclosureSEC source: 0001567619-20-008475 · doc1.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 633 F1 · kind: Disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as March 10, 2019 (the "Merger Agreement"), by and among the Issuer, NVIDIA International Holdings, Inc., a Delaware corporation ("Parent"), Teal Barvaz Ltd., a company organized under the laws of the State of Israel and a wholly owned subsidiary of Parent, and NVIDIA Corporation, a Delaware corporation in exchange for cash consideration of $125.00 per share (the "Per Share Merger Consideration"), subject to any applicable withholding taxes. Read SEC document |
| April 21, 2020 Filed Apr 21, 2020 23:13 UTC | SILICON LABORATORIES INC. SLAB · Entity 3682 | GrantCommon Stock, $0.0001 par value | 2,185 | $0.00 | $0.00 |
DisclosureSEC source: 0001681108-20-000029 · primary_doc.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,576 F1 · shares: Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of common stock per RSU. The RSUs will vest completely on the earlier of (i) the first (1st) anniversary of the date of grant, and (ii) the date one day prior to the Annual Meeting of Stockholders in the year following the grant date. Read SEC document |
| March 22, 2020 Filed Mar 24, 2020 22:33 UTC | BOX INC BOX · Entity 3932 | GrantEmployee Stock Option (right to buy) · Derivative | 31,666 | $0.00 Strike: $12.48 | $0.00 |
DisclosureSEC source: 0001209191-20-021004 · doc4.xml · derivative · entry 2 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,666 Underlying: Class A Common Stock · 31,666 shares Expires 2030-03-22 F3 · shares: 1/36 of the shares subject to the option vest on April 22, 2020 and 1/36 of the shares vest monthly thereafter, subject to the Reporting Person's continued service through each vesting date Read SEC document |
| March 22, 2020 Filed Mar 24, 2020 22:33 UTC | BOX INC BOX · Entity 3932 | GrantClass A Common Stock | 15,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-021004 · doc4.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,833 F1 · shares: Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. F2 · shares: 1/3 of the RSUs will vest on March 22, 2021. The remaining RSUs will vest annually thereafter over the following two years, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 21:36 UTC | Casper Sleep Inc. CSPR · Entity 131068 | GrantCommon Stock | 17,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-030852 · a4.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,998 F1 · shares: The Reporting Person received an award of 17,332 restricted stock units on March 5, 2020. The restricted stock units vest in full on March 5, 2021. Each restricted stock unit represents a right to receive one share of Issuer common stock upon vesting. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 21:32 UTC | Casper Sleep Inc. CSPR · Entity 131068 | PurchaseCommon Stock | 16,666 | $12.00 | $199,992.00 |
DisclosureSEC source: 0001104659-20-019298 · a4.xml · nonDerivative · entry 1 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,666 Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 22:57 UTC | RESIDEO TECHNOLOGIES, INC. REZI · Entity 1292 | Exercise / conversionRestricted Stock Units · Derivative | 5,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-057293 · doc4.xml · derivative · entry 2 LAZAR JACK R · CIK 0001277624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,578 shares Expires 2019-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Instrument converts to common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.